Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity.
about
Smoking, habitual tea drinking and metabolic syndrome in elderly men living in rural community: the Tianliao old people (TOP) study 02.Laboratory, epidemiological, and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesityApelin-13 decreases lipid storage in hypertrophic adipocytes in vitro through the upregulation of AQP7 expression by the PI3K signaling pathwayGreen tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivorsCurrent nutraceuticals in the management of osteoarthritis: a reviewGreen tea polyphenols reduce body weight in rats by modulating obesity-related genes.Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer.Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice.Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected].Quantification of total polyphenols, catechin, caffeine, L-theanine, determination of antioxidant activity and effect on antileishmanial drugs of ethiopian tea leaves extracts.Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extractDietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mRNA and its responsive genes in fructose-fed, ovariectomized rats.Green tea extract containing a highly absorbent catechin prevents diet-induced lipid metabolism disorderEffects of the green tea catechin (-)-epigallocatechin gallate on Trypanosoma brucei.Estrogen Receptor α Participates to the Beneficial Effect of Red Wine Polyphenols in a Mouse Model of Obesity-Related DisordersDiabetes is an inflammatory disease: evidence from traditional Chinese medicines.Analysis of low molecular weight metabolites in tea using mass spectrometry-based analytical methods.Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review.Green tea constituents (-)-epigallocatechin-3-gallate (EGCG) and gallic acid induce topoisomerase I- and topoisomerase II-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide.Therapeutic Potential of Epigallocatechin Gallate Nanodelivery SystemsActivation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells.Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK(®) Weight Loss Products: Results from the DILIN Prospective Study.White Tea extract induces lipolytic activity and inhibits adipogenesis in human subcutaneous (pre)-adipocytes.Pu-erh tea suppresses diet-induced body fat accumulation in C57BL/6J mice by down-regulating SREBP-1c and related molecules.Epigallocatechin-3-gallate-induced free-radical production upon adipogenic differentiation in bovine bone-marrow mesenchymal stem cells.Can EGCG reduce abdominal fat in obese subjects?A hot lunch for herbivores: physiological effects of elevated temperatures on mammalian feeding ecology.Evaluation of epigallocatechin gallate and epicatechin gallate effects on acrylamide-induced neurotoxicity in rats and cytotoxicity in PC 12 cells.
P2860
Q31068053-1589834F-E244-4F5B-916B-1E896661053AQ33652893-6DDA05DA-B917-4F31-AE5E-ACFA00E0BC34Q34062141-2DAF0BE1-817E-4E08-BB7D-F5F7CB68C5CBQ34253329-CD7736AF-3029-4BE5-96F3-9F03BF4DD059Q34291608-368C2BAB-AAF5-453C-9EAA-C92020816667Q34310244-E5E424AF-2BE1-41B0-895E-088666EEA1F8Q34381481-CF73EDEF-9367-4DA0-A2C6-173E34C428A9Q35105316-A9DA3A9D-5101-48FF-92C7-197FFB0DB602Q35135845-FA5ECA25-8290-4E6D-9768-2AF73F35DC86Q35740497-93F96E8B-11E4-4E48-9E6A-71D7EDDE4268Q36877501-46F534AF-6F04-4E20-9DCA-39D649427E00Q37152284-C2AF73C9-209A-4C5C-B756-5F9D857FF3A3Q37197043-1E51264B-3897-43C7-8BF8-3F182CEDC782Q37390521-33BD7E3B-9561-4B0C-B0BE-6553E5939BB4Q37574772-809A2DEF-66F3-44A1-A796-3787C6943AB4Q37825944-4FB69941-CBC8-4CDA-BF32-D09A95059B11Q38185433-2A61BD15-5643-4A47-BF3D-EC539325E1FEQ38904568-EE670FCF-3142-4929-9607-C118D207AACEQ39580025-5D541BD2-BC61-477C-91E7-A9AA246C8F08Q41169121-03898B59-2C64-44D5-9116-1D9592A7DDA2Q42170618-825BA805-3EF2-4A7C-BB1B-7D8848880188Q42175085-BEE3F5BA-F85B-4641-8CEA-DE89A6A2CB08Q43123247-E6A074AB-1E2D-4F05-96B7-B45EC896830BQ46247911-CFF4EBDA-5F66-49D4-AE07-0E80AC35AF96Q46729079-89CA4A87-3045-440A-9F7C-6BF0D66716EDQ46974080-CAA8EF30-E655-4448-BE16-137513773E71Q48054564-D9C132E1-B1DB-4ED2-9C06-904B5DF2D0BCQ48124672-00139905-BA8D-4548-9AF0-616D0CFF6059
P2860
Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity.
@ast
Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity.
@en
type
label
Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity.
@ast
Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity.
@en
prefLabel
Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity.
@ast
Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity.
@en
P2093
P1476
Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity.
@en
P2093
Chong-Su Cho
Hong-Gu Lee
Hyun-Seuk Moon
Tae-Gyu Kim
Yun-Jaie Choi
P356
10.1016/J.CBI.2007.02.008
P577
2007-02-20T00:00:00Z